Lantern Pharma Inc. (LTRN): Shareholders' Equity
$6.53M
As of 2025-12-31
-$3.22M
As of 2026-06-30
-51.1%
3-year compound annual growth
-19.8%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.53M | -69.2% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $21.19M | -48.2% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $40.91M | -27.0% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $56.04M | -21.7% | 2024-03-18, Balance as of period end |
| 2021-12-31 | $71.57M | +263.3% | 2023-03-20, Balance as of period end |
| 2020-12-31 | $19.70M | n/m | 2022-03-10, Balance as of period end |
| 2019-12-31 | $943.3K | n/a | 2021-03-10, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | $6.53M | -69.2% |
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | $5.89M | +289.6% |
| Mira Pharmaceuticals, Inc. (MIRA) | 2025-12-31 | $10.39M | +372.4% |
| MetaVia Inc. (MTVA) | 2025-12-31 | $5.33M | -32.8% |
| NewcelX Ltd. (NCEL) | 2025-12-31 | $7.25M | n/m |
| Traws Pharma, Inc. (TRAW) | 2025-12-31 | -$629.0K | n/m |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | $11.22M | n/m |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | $8.86M | +88.2% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $2.25M | +217.9% |
Compare LTRN, DCOY, MIRA, MTVA side by side · Screen every company in Pharmaceutical Preparations ↗